Adacel is a "booster" vaccine used to help prevent diphtheria, tetanus, and pertussis (whooping cough). This eMedTV resource describes how the vaccine works, explains how often it is given, and lists some of the side effects that may occur.
Common side effects of Adacel include fever and injection site redness, pain, or swelling. This article on the eMedTV Web site also lists some of the potentially serious side effects of the vaccine that should be reported to your doctor immediately.
The vaccine Adacel is licensed to prevent pertussis (whooping cough), tetanus, and diphtheria. This eMedTV page covers the uses of Adacel in more detail, including information on how it works, and explains whether the vaccine is suitable for children.
There is only one standard dose of Adacel, but certain factors will influence the timing of the vaccine. As this eMedTV resource explains, the standard recommended dosage is one 0.5 mL vaccine given as a single, one-time injection.
Immunosuppressants, tetanus immune globulin, and other vaccines may cause interactions with Adacel. This eMedTV page lists various types of immunosuppressant drugs that can interfere with Adacel and describes the potential effects of these interactions.
If you are ill, it is recommended to postpone vaccination with Adacel until you are feeling better. This eMedTV segment provides more warnings and precautions for Adacel, including information on who may not be able to safely get this vaccination.
At this time, Adacel is not recommended for women who are expecting. As this eMedTV article explains, no adequate studies have been done on pregnancy and Adacel. However, it is generally recommended that women receive this vaccine soon after giving birth.
Adacel is generally considered safe for use while breastfeeding. This article from the eMedTV archives offers a more in-depth look at breastfeeding and Adacel, including information on why it is best for women to get the vaccine soon after childbirth.
Currently, generic Adacel products are not allowed to be made in the United States. This page from the eMedTV library explains why generic versions of the vaccine cannot be made at this time and whether these laws are likely to change in the future.
